Search clinical trials for: Extended Release tablet

Total 14165 results

Pyramid Biosciences

Completed

A Study of PBI-200 With Ritonavir or Cobicistat in Healthy Volunteers

Drug-drug Interaction

United States
Lyndra Inc.
National Institute on Drug Abuse (NIDA)

Withdrawn

Study of LYN-014 in Individuals With Opioid Use Disorder Who Are Stable on Methadone Therapy

Opioid Use Disorder, Moderate
Otsuka Pharmaceutical Development & Commercialization...

Completed

Open-label, Single-dose Trial to Assess the Pharmacokinetics of Centanafadine Extended-release Capsules in Pediatric Participants With Attention-deficit Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder

United States
University of Pennsylvania

Completed

Biomarkers of Injectable Extended Release Naltrexone Treatment

Heroin Dependence | Opioid Dependence

United States
Ensysce Biosciences
Dr. Vince Clinical Research

Completed

A Study to Evaluate the Oral Abuse Potential of PF614 in Non-Dependent Recreational Opioid Users

Recreational Drug Use

United States
Ensysce Biosciences

Completed

A Study to Evaluate the Intranasal Abuse Potential of PF614 in Non-Dependent Recreational Opioid Users

Recreational Drug Use

United States
Overseas Pharmaceuticals, Ltd.
GX pharma technology (beijing) Co., Ltd

Active, not recruiting

An Open Label, Balanced, Randomized, 3×3 Latin Square Design Comparing of Brivaracetam Sustained-release Tablets and Brivaracetam Tablets in the Oral Comparative Pharmacokinetic(PK) Study in Chinese Healthy Adult Subjects Under Fasting Conditions.

Partial Seizure

China
Rhodes Pharmaceuticals, L.P.

Completed

Time Course of Response to Methylphenidate HCl ER Capsules in Children 6 to 12 Years With ADHD in Classroom Setting

ADHD | Attention Deficit Hyperactivity Disorder

United States
Overseas Pharmaceuticals, Ltd.
Guangzhou Kangqi Medical Technology Co., LTD

Active, not recruiting

Felodipine Controlled Release Tablets and Felodipine Sustained Release Tablets in Healthy Subjects Under Fasting State Comparative Pharmacokinetic Study

Hypertension

China
Lars Tanum
Oslo University Hospital; Haukeland University Hospital; The Hospital of Vestfold and other collaborators

Completed

Long Acting Naltrexone for Opioid Addiction: Focus on Sustained Abstinence and Recovery (NaltRec)

Opioid-use Disorder

Norway
TaiRx, Inc.

Completed

Safety and Pharmacokinetic Study of CVM-1118 Extended-Release in Advanced Cancer Patients

Advanced Cancer

Taiwan
Excalibur Pharmaceuticals, Inc.

Completed

Randomized, Crossover, Multi-Dose Pharmacokinetics of EXCL-100 Pirfenidone-Sustained Release Tablet and Esbriet in Healthy Volunteers

Idiopathic Pulmonary Fibrosis

United States
Zogenix, Inc.

Completed

Pharmacokinetics and Metabolism of Hydrocodone Bitartrate Extended-Release (HC-ER) in Subjects With Renal Impairment

Renal Impairment
Zogenix, Inc.

Completed

To Assess the Rate and Extent of Absorption of Hydrocodone From 20 mg Hydrocodone Bitartrate Extended-Release Capsules

Healthy
Zogenix, Inc.

Completed

A Multicenter Active Comparator Study of HC-ER in Adults Following Bunionectomy Surgery

Postoperative Pain
Zogenix, Inc.

Completed

A Study to Determine the Influence of Co-ingestion of Alcohol on Hydrocodone Bitartrate Extended Release (HC-ER)

Healthy
Zogenix, Inc.

Completed

A Safety, Tolerability and Pharmacokinetic Dose Escalation Study of HC-ER in Patients With Osteoarthritis Pain

Osteoarthrosis
Eisai Limited

Suspended

A Study to Evaluate the Relative Bioavailability of E7386 Following Oral Administration of Targeted Release (TR) Tablets Compared to an E7386 Immediate Release (IR) Tablet in Healthy Adult Participants

Healthy Volunteers

United Kingdom
Apkar Apkarian
National Institutes of Health (NIH); National Center for Complementary and...

Completed

Placebo In Chronic Back Pain (Phase 2) (PICP2)

Chronic Low Back Pain

United States
J3 Bioscience, Inc.
Advanced Clinical Research, Inc.; Phil Triolo and Associates LC

Completed

Use of J3 Bioscience Lubricating Intravaginal Ring VR101 to Relieve the Symptoms of Vaginal Dryness

Postmenopausal Symptoms | Menopause Related Conditions

United States
Al-Azhar University

Completed

Efficacy of Lithium Against Chemotherapy Induced Neutropenia in Breast Cancer Patients

Neutropenia

Egypt
Al-Azhar University

Completed

Treatment of Venous Malformation

Venous Malformation

Egypt
NYU Langone Health

Completed

Metformin Prostate Cancer Adjuvant Trial

Prostate Cancer | Prostate Cancer Recurrent

United States
Indivior Inc.

Completed

SUBLOCADE Rapid Initiation Study

Opioid-use Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

A Trial Evaluating the Long-term Safety and Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder

Attention Deficit Hyperactivity Disorder | Attention Deficit Disorder

United States
University Hospitals Bristol and Weston NHS Foundation...

Completed

Timed Release Tablet Prednisone in Polymyalgia Rheumatica

Polymyalgia Rheumatica

United Kingdom
Wake Forest University Health Sciences

Completed

Extended Release Local Anesthetic for Postsurgical Pain After Posterior Colporrhaphy and Perineorrhaphy

Postoperative Pain

United States
INTRuST, Post-Traumatic Stress Disorder - Traumatic...
U.S. Army Medical Research and Development Command

Completed

Tramadol Extended-Release (ER) for Posttraumatic Stress Disorder (PTSD)

Post-Traumatic Stress Disorder

United States
Abbott

Completed

Bio-Equivalence Study of Budesonide Prolonged-release Tablets 9 Mg In Healthy Human Adult Subjects

Healthy Subjects | Healthy Participants | Bioequivalence | Human Volunteers

India
The Affiliated Nanjing Drum Tower Hospital of Nanjing...
The First Affiliated Hospital of Soochow University; The Affiliated Hospital... and other collaborators

Active, not recruiting

The Efficacy and Safety of Prostatectomy for Castration-Naive Oligometastatic Prostate Cancer

Prostatectomy | Oligometastatic Prostate Cancer | Abiraterone

China
Kasr El Aini Hospital

Completed

Low Dose Tadalafil for Treatment of Female OAB Syndrome: Short Term Follow up.

Female Patients With Overactive Bladder Syndrome or Female Patients With Urgency or Urgency Urinary Incontinence

Egypt
NLS Pharmaceutics

Completed

Four-week Study of the Safety and Efficacy of NLS-2 (Mazindol Extended Release) in the Treatment of Narcolepsy

Narcolepsy | Excessive Daytime Sleepiness | Cataplexy Narcolepsy

United States
Taiwan Liposome Company

Completed

Extended and Controlled Release Liposomal Formulated Dexamethasone for Chronic Knee OA Pain (EXCELLENCE)

Osteoarthritis of the Knee

United States, Australia
Carilion Clinic
Virginia Polytechnic Institute and State University

Completed

Measuring Opioid Use After Rotator Cuff Repair: Comparing the Effects of Standard vs. Extended-release Nerve Blocks

Rotator Cuff Tears

United States
Supernus Pharmaceuticals, Inc.

Completed

Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD

Attention-Deficit/Hyperactivity Disorder (ADHD)

United States
TWi Biotechnology, Inc.

Completed

A Study of AC-201 Controlled-Release Tablet (CR Tablet) in Patients With Gout

Gout

Taiwan
Valenta Pharm JSC

Completed

Efficacy and Safety of Buspirone, Sustained-release Tablets, 15 mg in Patients With Autonomic Dysfunction Syndrome Accompanied by Vertigo

Vertigo | Autonomic Dysfunction

Russian Federation
Wake Forest University Health Sciences

Withdrawn

Long Acting Buprenorphine Injection Compared to Sublingual Buprenorphine/Naloxone Films

Opioid Use
University of North Carolina, Chapel Hill
Flexion Therapeutics, Inc.

Completed

Effect of Zilretta Injection

Osteoarthritis, Knee

United States
NYU Langone Health
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Extended-release Naltrexone and Care Management for Alcohol Dependent Frequent Emergency Department Users

Alcohol Dependence | Alcohol Use Disorder

United States
University of Kansas Medical Center

Completed

The Effect of Intra-articular Bilateral Knee Injections of Zilretta on Performance Measures in Adults With Knee OA

Knee Osteoarthritis

United States
Diurnal Limited
National Institutes of Health Clinical Center (CC)

Completed

Comparison of Two Forms of Hydrocortisone in Patients With Congenital Adrenal Hyperplasia

Adrenogenital Syndrome | Congenital Adrenal Hyperplasia | 21-Hydroxylase Deficiency

United States
Eisai Inc.

Completed

Rabeprazole Extended-Release 50 mg vs. Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD)

Gastroesophageal Reflux Disease (GERD)

United States
Pauls Stradins Clinical University Hospital

Completed

Coronary Artery Disease Progression in Patients With Prediabetes

Coronary Artery Disease | Atherosclerosis | Prediabetic State

Latvia
Overseas Pharmaceuticals, Ltd.

Completed

To Evaluate the Food Effect and the Absorption Profile of Ibuprofen Modified-Release Tablets 800 mg

Chronic Pain

China
Indiana University

Completed

Endoscopic Ultrasound (EUS)-Guided Ablation of Pancreatic Cysts

Pancreatic Cyst | Pancreatic Intraductal Papillary-Mucinous Neoplasm | Cystadenoma, Mucinous | Papillary Mucinous Cystadenoma, Borderline Malignancy

United States
Overseas Pharmaceuticals, Ltd.
Virginia Contract Research Organization Co., Ltd.

Terminated

To Evaluate the Food Effect and the Absorption Profile of Ibuprofen Controlled-Release Tablets 600 mg in Comparison to the Reference Standard Ibuprofen Tablets in Normal Healthy Volunteers

Pain Control

Taiwan
Teva Branded Pharmaceutical Products R&D, Inc.
Syneos Health

Completed

Study to Evaluate the Analgesic Efficacy and Safety of Hydrocodone Bitartrate/Acetaminophen Immediate-Release Tablets in Participants With Moderate to Severe Pain Following Bunionectomy

Pain

United States
CalciMedica, Inc.

Withdrawn

A Placebo-Controlled Study of Auxora for the Extended Treatment of High- Risk Patients With Critical COVID-19 Pneumonia (CARDEA-Plus)

Pneumonia

United States
Sanofi

Completed

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period (LixiLan-G)

Type 2 Diabetes Mellitus

Estonia, Italy, Israel, United States, Canada, Germany, Romania, Slovakia, Spain

3

Subscribe